Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hemoglobin a1c levels and the risk of cardiovascular disease in people without known diabetes: a population-based cohort study in Japan.
Goto A, Noda M, Matsushita Y, Goto M, Kato M, Isogawa A, Takahashi Y, Kurotani K, Oba S, Nanri A, Mizoue T, Yamagishi K, Yatsuya H, Saito I, Kokubo Y, Sawada N, Inoue M, Iso H, Kadowaki T, Tsugane S; JPHC Study Group. Goto A, et al. Among authors: isogawa a. Medicine (Baltimore). 2015 May;94(17):e785. doi: 10.1097/MD.0000000000000785. Medicine (Baltimore). 2015. PMID: 25929925 Free PMC article.
Coffee consumption and risk of type 2 diabetes mellitus.
Isogawa A, Noda M, Takahashi Y, Kadowaki T, Tsugane S. Isogawa A, et al. Lancet. 2003 Feb 22;361(9358):703-4. doi: 10.1016/S0140-6736(03)12586-X. Lancet. 2003. PMID: 12606201 No abstract available.
Taste preferences and body weight change in Japanese adults: the JPHC Study.
Matsushita Y, Mizoue T, Takahashi Y, Isogawa A, Kato M, Inoue M, Noda M, Tsugane S; JPHC Study Group. Matsushita Y, et al. Among authors: isogawa a. Int J Obes (Lond). 2009 Oct;33(10):1191-7. doi: 10.1038/ijo.2009.153. Epub 2009 Jul 28. Int J Obes (Lond). 2009. PMID: 19636316
Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial.
Ueki K, Sasako T, Okazaki Y, Kato M, Okahata S, Katsuyama H, Haraguchi M, Morita A, Ohashi K, Hara K, Morise A, Izumi K, Ishizuka N, Ohashi Y, Noda M, Kadowaki T; J-DOIT3 Study Group. Ueki K, et al. Lancet Diabetes Endocrinol. 2017 Dec;5(12):951-964. doi: 10.1016/S2213-8587(17)30327-3. Epub 2017 Oct 24. Lancet Diabetes Endocrinol. 2017. PMID: 29079252 Clinical Trial.
39 results